| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcbdc3c1c204e3131c6b5648a6ee316d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2300-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-1614
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-161 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L3-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-62 |
| filingDate |
2015-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_195a6847258e2236c6edf3b93e8b438b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_597918efcce204239c972471543c847b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abf3aab9901c0d4f477fd01b9b4559e9 |
| publicationDate |
2017-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2017025019-A |
| titleOfInvention |
Amyloid β-fibrinolytic agent, therapeutic / prophylactic agent for diseases caused by fibrosis of amyloid β, and food composition for treatment / prevention |
| abstract |
An amyloid β-fibrinolytic agent containing a natural product as an active ingredient, a therapeutic or preventive agent for a disease caused by fibrillation of amyloid β, and a food composition for the treatment or prevention of a disease caused by fibrillation of amyloid β To provide things. An amyloid β fibril degrading agent, a therapeutic or prophylactic agent for a disease caused by fibrillation of amyloid β, and fibrillation of amyloid β, which contains a dry powder, ground product and / or extract of earthworm as an active ingredient It is a food composition for the treatment or prevention of diseases caused by. The disease caused by amyloid β fibrosis is preferably Alzheimer's disease. [Selection] Figure 1 |
| priorityDate |
2015-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |